News Focus
News Focus
Followers 616
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: ZincFinger post# 81522

Tuesday, 02/18/2014 6:25:55 PM

Tuesday, February 18, 2014 6:25:55 PM

Post# of 146478
Good post that answers some newbie questions. ;)




In Reply to 'ZincFinger'
You have been here throughout repeated discussions about them having to delay the data gathering phase of the toxicology testing to make more drugs

AND how that was because the toxicology was so low that much larger amounts of drugs would be needed because the FDA requires testing to the point of toxicity or to the maximum feasible dose if there is NO toxicity below that

AND about how good that was because it meant that the odds of success in a clinical trial were much greater AND all the reasons why that was so

AND about how they'd have to wait for the new lab to produce that much larger amount of drugs

AND about how the low toxicity meant that the probability of an early approval and many other FDA expediting measures would mean that the short delay for the higher amount of drugs to b e made in the new labs would be more than compensated for by the time savings of all that

And much much more.

All of that repeated many times while you were here and yet you apparently have no idea why they are not yet in the final stage (data gathering) of tox (while the EARLY stage: dose ranging has already been completed! Did you miss THAT too?)

It does raise questions.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News